Mabel Mardones, MD, discusses findings from the phase 3 perservERA trial presented at ASCO 2026.
Mabel Mardones, MD
Advertisement
Mabel Mardones, MD, is a medical oncologist at Rocky Mountain Cancer Centers.
Articles by Mabel Mardones, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Accepts NDA for Daraxonrasib in Metastatic Pancreatic Cancer
2
Advanced Renal Cell Carcinoma: Tailoring Second-Line Therapy After Prior Immunotherapy
3
FDA Approves Zidesamtinib for Previously Treated ROS1-Positive NSCLC
4
Teclistamab/Talquetamab Reduces Risk of Progression by 89% in R/R Multiple Myeloma
5